Not All Depression is the Same.
How We Treat Depression Differently
Most clinics prescribe by trial and error. We track whether treatments work at every appointment for every patient — and use that data to match the right treatment to you, faster.
The Standard Approach to Depression Treatment
Your provider picks a medication from general guidelines, you wait six to eight weeks, and if it doesn't help, you try another one. If that doesn't work either, you try a third.
Psychiatry has lacked a systematic way to know in advance which treatment will work for a given patient. Your endocrinologist can check for thyroid antibodies to determine whether your low thyroid is autoimmune and prescribe accordingly. Until now, your psychiatrist has been working without that kind of biological subtyping.
We built something different. At Live Well Psychiatry, we identify your depression subtype at the first appointment, then measure how you're doing at every appointment after that. We collect this data clinic-wide and analyze which treatments produce the best results for each subtype.
When your provider recommends a treatment, that recommendation is backed by real outcome data from our practice — not a pharmaceutical rep's summary, and not a guideline written without knowledge of your specific profile.
We Measure How You're Doing. Every Visit.
Before every appointment, you complete our 23-item rating scale, the LW-23. It takes about three minutes and covers depression symptoms, anxiety type, and current stress level.
Standard depression scales like the PHQ-9 were designed for screening — detecting whether depression is present. But screening and treatment guidance are different jobs. The PHQ-9 combines insomnia and hypersomnia into a single answer, even though they point toward different treatments. It combines sadness, hopelessness, and irritability into one question, even though each has different underlying biology.
The LW-23 was purpose-built for treatment monitoring. It separates symptoms that standard scales lump together, identifies which type of anxiety you're experiencing, and tracks your current stress level — which our data shows directly changes whether medication works.
- Designed for screening
- Insomnia + hypersomnia combined
- One pleasure question
- Sadness, hopelessness, irritability merged
- No stress measurement
- Anxiety intensity only, not type
- Designed for treatment guidance
- Insomnia and hypersomnia tracked separately
- Two pleasure dimensions measured
- Sadness, hopelessness, irritability distinguished
- Stress measured every visit
- Five anxiety types monitored
The LW-23 is a clinical tool designed by our physicians and refined through continuous use with over 1,700 patients. The treatment data it generates powers our outcome analytics — and the discoveries those analytics have produced are evidence that the instrument captures real clinical signal.
We Analyze What Works. And What Doesn't.
We aggregate outcome scores across our entire patient population and analyze which treatments produce improvement, broken down by depression subtype, by medication, and by stress level.
This is not something other practices do. The few clinics that collect rating scales use them only for the individual patient sitting in front of them. We analyze the data across thousands of patients to find patterns that individual cases can't reveal.
When treatment is matched to your specific depression subtype, improvement rises steadily over the first several visits. When it isn't matched, improvement barely moves regardless of which medication is used.
Depression is not one disease. Our data identifies distinct depression subtypes based on personality patterns and attention characteristics measured at your intake visit. Your subtype determines which treatments are most likely to help — and which ones won't.
Two Discoveries That Changed How We Treat Depression
Our data has revealed treatment-response patterns absent from the published psychiatric literature. Two findings have changed our clinical approach.
1. Stress Is an Invisible Treatment Headwind
Whether you're under significant life stress during treatment dramatically changes your likelihood of responding to medication — on the same medications, at the same doses.
Each bar represents a different medication. The gap between groups is consistent across every drug class we've analyzed.
No major depression treatment trial has measured this. STAR*D — the largest depression study ever conducted — never recorded whether patients were under life stress during treatment. The field has been evaluating whether medications work without controlling for the variable that most determines whether they can.
We measure your stress level at every visit. When your scores aren't improving and your stress is high, your provider knows the medication may not have failed — the circumstances are working against it. That changes the clinical decision: we may continue the current treatment and address the stress, rather than cycling through a medication change that faces the same headwind.
2. Depression and ADHD Must Be Treated Together
In our patient population, three out of four patients seeking treatment for depression also meet criteria for ADHD — and it changes how treatment works.
When ADHD and depression are both present, the ADHD must be treated for a full antidepressant response. For one of our five depression subtypes, treating ADHD alone often leads to sustained benefit for both conditions. Treating this subtype with an antidepressant alone often leads to worsening depression.
What appears to be treatment-resistant depression is often untreated ADHD. When ADHD is addressed, the "depression" frequently resolves — without an antidepressant.
Published guidelines recommend treating depression with an antidepressant first and considering ADHD separately. Our outcome data, across thousands of patients, consistently shows the reverse sequence produces better results for one of our depression subtypes — and that ADHD must be treated for full response whenever it is present in any subtype.
What This Means for You
When you come to Live Well Psychiatry, your first visit includes an assessment that identifies your specific depression subtype — not just "you have depression," but which kind, based on your attention characteristics and symptom profile.
Your provider selects a treatment based on outcome data: which medications have produced improvement in patients with your profile. At every visit, your LW-23 scores are tracked against your baseline and against what our data predicts for a responder. If your trajectory diverges, your provider adjusts early — not months later.
- Pick a medication from guidelines
- Wait 6–8 weeks
- Ask "how do you feel?"
- If not better, try another one
- Repeat until something works
- Identify your depression subtype
- Select treatment from outcome data
- Measure symptoms at every visit
- Compare your trajectory to the data
- Adjust early based on what the numbers show
This is not a guarantee — individual responses vary. But it replaces trial and error with treatment guided by evidence from patients like you.
Questions Patients Ask
Is this the same as genetic testing for antidepressants?
No. Pharmacogenetic testing tells you how your body metabolizes certain medications — it can flag potential side effects or dosing issues. Our approach answers a different question: given your specific depression profile, which treatments have actually produced improvement in patients like you? One looks at your DNA. Ours looks at treatment outcomes.
What if I've already tried several medications that didn't work?
Many patients labeled "treatment-resistant" were receiving the wrong treatment for their depression type. When the treatment matches the subtype, response rates increase substantially. A fresh evaluation that classifies your depression subtype and reviews what you've already tried can reveal why previous treatments failed and what's more likely to work.
How is a "depression subtype" determined?
At your intake appointment, we assess personality dimensions and attention patterns alongside your depression symptoms. These characteristics are stable traits — they don't change with your mood — which makes them reliable classifiers. Your subtype reflects how your brain tends to process stress and emotion, and it predicts which treatment mechanisms are most likely to help you.
Do you treat patients across Idaho?
Yes. Live Well Psychiatry provides telehealth psychiatric services to patients throughout Idaho. Our approach works the same whether you're in Boise, Twin Falls, Idaho Falls, or anywhere in the state.
What does the rating scale involve?
The LW-23 is a 23-item questionnaire you complete on your device before each appointment. It takes about three minutes. The questions cover depression symptoms, anxiety type, and current stress level. Your provider sees your scores before walking into the appointment, and your trend over time is tracked automatically.
Ready to Try a Different Approach?
If you're frustrated with depression treatment that isn't working, or if you're looking for a provider who measures results rather than guessing, we'd like to help.
Schedule an AppointmentFindings based on outcome data from Live Well Psychiatry patients (N > 1,000 with evaluable depression outcomes). All findings are provider-agnostic — consistent across multiple clinicians. Response defined as ≥50% improvement in core depression symptoms. STAR*D comparison references published per-step remission rates. Individual results vary. Live Well Psychiatry serves patients throughout Idaho via telehealth.